Classification
- Anatomical main groupCCardiovascular system
- Therapeutic subgroupC10
- Pharmacological subgroupC10A
- Chemical subgroupC10AXOther lipid modifying agents
- Chemical substanceC10AX13Evolocumab
Where it is registered
Each register and historical list with its number of registrations and a few of them.
United States
FDA · 4 registrations
Spain
AEMPS · 3 registrations
Netherlands
CBG-MEB · 3 registrations
At a glance
- ATC code
- C10AX13
- ATC group
- Cardiovascular system
- Registers
- 9
- Historical lists
- 2
- Registrations
- 22
- With their own page
- 18
- Companies
- 8
All medicines with Evolocumab
Human medicines from every register that match Evolocumab by substance or by name, a page at a time, so the count can differ from the registrations above. Strengths and packs are on each medicine’s page.
22 search results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| Repatha | United States | 140MG/ML | injectable | Marketed | Amgen INC |
| Repatha | United States | 140MG/ML | Injection | Marketed | Amgen Inc. |
| Repatha | United States | 140MG/ML | Injection | Not marketed | Amgen Inc. |
| Repatha | United States | 420MG/3.5ML | Injection | Not marketed | Amgen Inc. |
| Repatha 140 MG Solucion Inyectable en Pluma Precargada | Spain | 140 mg/ml | solución inyectable en pluma precargada | Marketed | Amgen Europe B.V. |
| Repatha 140 MG Solucion Inyectable en Pluma Precargada | Spain | 140 mg/ml | solución inyectable en pluma precargada | Marketed | Amgen Europe B.V. |
| Repatha 140 MG Solucion Inyectable en Pluma Precargada | Spain | 140 mg/ml | solución inyectable en pluma precargada | Marketed | Amgen Europe B.V. |
| Repatha | European Union | Authorised | Amgen Europe B.V. | ||
| Repatha 420 mg oplossing voor injectie in een patroon | Netherlands | Oplossing voor injectie | Authorised | Amgen Europe B.V. | |
| Repatha 140 mg oplossing voor injectie in een voorgevulde pen | Netherlands | Oplossing voor injectie | Authorised | Amgen Europe B.V. | |
| Repatha 140 mg oplossing voor injectie in een voorgevulde spuit | Netherlands | Oplossing voor injectie | Authorised | Amgen Europe B.V. | |
| Repatha | Canada | 140 MG / ML | Solution | Marketed | Amgen Canada INC |
| Repatha | Brazil | Authorised | Amgen Biotecnologia do Brasil Ltda. | ||
| Repatha® | Serbia | 140mg | rastvor za injekciju u napunjenom injekcionom penu | Authorised | Amicus SRB D.O.O. |
| Repatha® | Serbia | 140mg | rastvor za injekciju u napunjenom injekcionom penu | Authorised | Amicus SRB D.O.O. |
| Repatha Solution for Injection in Pre-Filled Autoinjector 140MG/ML | Singapore | 140mg/ml | injection, solution | Authorised | Amgen Biotechnology Singapore Pte LTD |
| Repatha Solution for Injection in Pre-Filled Syringe 140MG/ML | Singapore | 140 mg/ml | injection, solution | Authorised | Amgen Biotechnology Singapore Pte LTD |
| Repatha | Croatia | Marketed | |||
| REPATHA 140 mg/ml Solution For Injection | Saudi Arabia | Authorised | Amgen Manufacturing Limited | ||
| REPATHA 420 mg Solution for Injection in Cartridge | Saudi Arabia | Authorised | Patheon INC | ||
| Repatha | Canada | 120 MG / ML | Solution | Cancelled | Amgen Canada INC |
| REPATHA 140 mg | Romania | 140mg | sol inj. in pen preumplut | Status unknown | Amgen Europe B.V. |